课题基金 / 基金详情

Production of an allergic inflammation model using human lungs resected by a surgical operation and its application to drug discovery for the treatment of asthma

Production of an allergic inflammation model using human lungs resected by a surgical operation and its application to drug discovery for the treatment of asthma
利用外科手术切除的人肺制作过敏性炎症模型及其在治疗哮喘的药物发现中的应用
批准号:
17590478
负责人:
ABE Masayoshi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

ABE Masayoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In order to resolve a problem concerning species differences in pharmacological science, we tried to make an inflammation model using human lung tissues obtained from patients with lung cancer after surgical resection. When the chopped lung fragments passively sensitized with human IgE were incubated with anti-human IgE antibody, a significant amount of cysteinyl-leukotrienes (cysLTs) was generated in comparison with the control (without anti-IgE). The addition of human C3a or C5a alone did not generate cysLTs. The co-addition, however, of C5a at doses of 1.0 ng/ml to the anti-IgE antibody further potentiated cysLT production. Consequently, an allergic inflammation model in which complement activation was involved as a pathophysiological mechanism was produced. Either a novel C5a receptor complementary peptide or a C5a receptor antagonist inhibited cysLT production in a dose-dependent manner by the human lung fragments following the anaphylactic reaction in the presence of 1 ng/ml C5a. … More Since there are consideable species differences in primary structure of anaphylatoxins and those receptors, this model using human lung tissues may be valuable to perform screening for a novel drug. In contrast, the shortage of suitable human tissues and lack of methods for stable preservation are hindering to produce an adequate model using human tissues. After lung tissues were obtained from patients with lung cancer, they were kept at -5℃ or 4℃ for as many as 5 days, and then they were histologically and biochemically examined. Although the tissues preserved at-5℃ had an almost normal morphology with intact cilia on bronchial epithelium and normal endothelium, the tissues stored at 4℃ showed degradation of these structures. Single-stranded DNA, a sign of DNA cleavage, was frequently noted in tissues stored at 4℃, but only rarely observed at -5℃. A significant amount of cysLTs was generated by anaphylactic reaction from tissues stored at 5℃ for 3 days, but there was no response to antibody stimulation from tissues at 4℃. Therefore, such the novel preservation of human tissues as super-cooling system may facilitate availability of human tissues in medical science. Less
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
補体系と炎症
补体系统与炎症
DOI: --
发表时间: 2006
期刊: 臨床病理 54
影响因子: --
作者: [Shirai N, Sugimoto M, Kodaira C, Nishino M, Ikuma M, Kajimura M, Ohashi K, Ishizaki T, Hishida A, Furuta T, 阿部 正義]
通讯作者: 阿部 正義
Contribution of anaphylatoxins to allergic inflammation in human lungs
过敏毒素对人类肺部过敏性炎症的影响
DOI: --
发表时间: 2005
期刊: Microbiol.Immunol. 49
影响因子: --
作者: [M.Abe, et al.]
通讯作者: et al.
DOI: 10.1016/j.freeradbiomed.2005.10.057
发表时间: 2006-03-15
期刊: FREE RADICAL BIOLOGY AND MEDICINE
影响因子: 7.4
作者: [Abe, M, Hayashi, Y, Tanaka, K]
通讯作者: Tanaka, K
DOI: --
发表时间: 2006-07
期刊: Rinsho byori. The Japanese journal of clinical pathology
影响因子: --
作者: [M. Abe]
通讯作者: M. Abe
6
    Analysis for roles of complement and arachidonate metabolites in occurrence and progression of ARDS.
    • 批准号:
      03670403
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      1991
    • 负责人:
      ABE Masayoshi
    • 依托单位:
    国内基金
    海外基金
    大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
    • 批准号:
      30873315
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2008
    • 负责人:
      周兆山
    • 依托单位:
    调节性T细胞和共刺激分子在过敏原早期暴露诱导哮喘免疫耐受中的作用机制研究
    • 批准号:
      30740048
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2007
    • 负责人:
      李海潮
    • 依托单位:
    CBP介导STAT4/STAT6相互拮抗在哮喘Th失衡中的机制
    • 批准号:
      30672268
    • 项目类别:
      面上项目
    • 资助金额:
      28.0万元
    • 批准年份:
      2006
    • 负责人:
      符州
    • 依托单位: